Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Merck
Colorcon
Express Scripts
AstraZeneca

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Litigation Details for AbbVie Inc. v. Roxane Laboratories Inc. (D. Del. 2012)

See Plans and Pricing

« Back to Dashboard

AbbVie Inc. v. Roxane Laboratories Inc. (D. Del. 2012)

Docket   Start Trial Date Filed 2012-04-10
Court District Court, D. Delaware Date Terminated 2013-06-28
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To Christopher J. Burke
Parties ABBOTT LABORATORIES; ABBVIE INC.; ROXANE LABORATORIES INC.
Patents 6,037,157; 6,703,403; 7,148,359; 7,364,752
Attorneys Barbara R. Rudolph; Derek James Fahnestock; Jennifer A. Johnson; Mary B. Graham; Mary Matterer; Maryellen Noreika; Mindy L. Ehrenfried; Roger J. Chin
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in AbbVie Inc. v. Roxane Laboratories Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for AbbVie Inc. v. Roxane Laboratories Inc. (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-04-12 10 of Expiration of Patent: Patent No. 6,037,157: June 26, 2016; Patent No. 6,703,403: June 26, 2016.Thirty… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2012 28 June 2013 1:12-cv-00457 830 Patent None District Court, D. Delaware External link to document
2012-07-23 29 Counterclaims Directed to U.S. Patent Nos. 7,148,359 B2 and 7,364,752 B1 filed by Abbott Laboratories…2012 28 June 2013 1:12-cv-00457 830 Patent None District Court, D. Delaware External link to document
2013-05-28 64 the '497 patent"); 5,674,882 ("the '882 patent"); 6,037,157 ("the '… The '352 patent, the '752 patent, the '497 patent, the '157 patent, and the '403…Delaware patents-in-suit (the '497 patent, the '157 patent, and the '403 patent), all of….S. Patent Nos. 5,541,206 ("the '206 patent"); 5,635,523 ("the '523 patent"… '359 patent and the '752 patent. 2 (D.I. 8 at~ 16) None of the other patents listed in the External link to document
2012-04-12 9 ; 7,364,752 B1; 6,648,497; 6,037,157; 6,703,403 B2;. (Tigan, Jeremy) (Entered: 04/12/2012) 12 April… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; …2012 28 June 2013 1:12-cv-00457 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Harvard Business School
Medtronic
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.